
Poultry Vaccines Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
Description
Poultry Vaccines Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
Global Poultry Vaccines Market will register a 7.1% CAGR from 2024 to 2032, driven by escalating awareness about the benefits of vaccination in preventing poultry diseases. The World Organisation for Animal Health (WOAH) noted in its 2024 report that the global poultry vaccine market saw a 12% increase in the adoption of advanced vaccine technologies from 2023 to 2024. Advances in vaccine technology, such as the development of more effective and safer vaccines, have also played a crucial role.
Furthermore, the rising global demand for poultry products has pressured producers to enhance flock health and productivity, boosting the demand for vaccination. Government initiatives promoting animal health and biosecurity measures support market expansion by encouraging vaccine use and providing subsidies for poultry health programs.
The poultry vaccines industry is sorted based on product, disease type, application, dosage form, end-user, and region.
The inactivated vaccines segment will showcase robust growth over the study period, due to their proven efficacy in providing robust immunity against various poultry diseases. These vaccines are valued for their stability and safety, which reduces the risk of vaccine-related complications and enhances overall flock health. Additionally, inactivated vaccines are less likely to cause disease outbreaks compared to live vaccines, making them a preferred choice for managing poultry health in large-scale operations. As poultry producers seek reliable solutions to ensure consistent production and minimize losses, the preference for inactivated vaccines continues to grow.
The layer segment will seize a noteworthy poultry vaccines market share by 2032, due to the focus on optimizing egg production and quality. As layer operations expand to meet the rising demand for eggs, there is a heightened emphasis on preventing diseases that can affect egg-laying efficiency and overall flock health. Vaccination programs targeting layers help ensure the continuity of production and reduce the risk of disease outbreaks that could lead to substantial economic losses. Consequently, the growth of layer poultry operations drives demand for vaccines specifically designed to protect and enhance the health of egg-laying hens.
Europe poultry vaccines market will register a decent growth pace through 2032, driven by stringent regulatory frameworks that prioritize animal health and biosecurity, encouraging the use of vaccines to prevent disease outbreaks. Additionally, advancements in veterinary healthcare and a growing focus on sustainable poultry farming practices are pushing for improved flock management and disease control. The increasing consumer demand for high-quality, safe poultry products has prompted producers across Europe to invest in comprehensive vaccination programs.
Global Poultry Vaccines Market will register a 7.1% CAGR from 2024 to 2032, driven by escalating awareness about the benefits of vaccination in preventing poultry diseases. The World Organisation for Animal Health (WOAH) noted in its 2024 report that the global poultry vaccine market saw a 12% increase in the adoption of advanced vaccine technologies from 2023 to 2024. Advances in vaccine technology, such as the development of more effective and safer vaccines, have also played a crucial role. Furthermore, the rising global demand for poultry products has pressured producers to enhance flock health and productivity, boosting the demand for vaccination. Government initiatives promoting animal health and biosecurity measures support market expansion by encouraging vaccine use and providing subsidies for poultry health programs. The poultry vaccines industry is sorted based on product, disease type, application, dosage form, end-user, and region. The inactivated vaccines segment will showcase robust growth over the study period, due to their proven efficacy in providing robust immunity against various poultry diseases. These vaccines are valued for their stability and safety, which reduces the risk of vaccine-related complications and enhances overall flock health. Additionally, inactivated vaccines are less likely to cause disease outbreaks compared to live vaccines, making them a preferred choice for managing poultry health in large-scale operations. As poultry producers seek reliable solutions to ensure consistent production and minimize losses, the preference for inactivated vaccines continues to grow. The layer segment will seize a noteworthy poultry vaccines market share by 2032, due to the focus on optimizing egg production and quality. As layer operations expand to meet the rising demand for eggs, there is a heightened emphasis on preventing diseases that can affect egg-laying efficiency and overall flock health. Vaccination programs targeting layers help ensure the continuity of production and reduce the risk of disease outbreaks that could lead to substantial economic losses. Consequently, the growth of layer poultry operations drives demand for vaccines specifically designed to protect and enhance the health of egg-laying hens. Europe poultry vaccines market will register a decent growth pace through 2032, driven by stringent regulatory frameworks that prioritize animal health and biosecurity, encouraging the use of vaccines to prevent disease outbreaks. Additionally, advancements in veterinary healthcare and a growing focus on sustainable poultry farming practices are pushing for improved flock management and disease control. The increasing consumer demand for high-quality, safe poultry products has prompted producers across Europe to invest in comprehensive vaccination programs.
Table of Contents
195 Pages
- Chapter 1 Methodology and Scope
- 1.1 Market scope and definitions
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
- Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
- Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Rising demand for poultry products
- 3.2.1.2 Increased outbreaks of poultry diseases
- 3.2.1.3 Technological advancements in vaccine development
- 3.2.2 Industry pitfalls and challenges
- 3.2.2.1 High cost associated with vaccine development and production
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.5 Porter's analysis
- 3.6 PESTEL analysis
- Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company matrix analysis
- 4.3 Competitive analysis of major market players
- 4.4 Competitive positioning matrix
- 4.5 Strategy dashboard
- Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Attenuated live vaccines
- 5.3 Inactivated vaccines
- 5.4 Recombinant vaccines
- 5.5 Other vaccine types
- Chapter 6 Market Estimates and Forecast, By Disease Type, 2021 – 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Newcastle disease
- 6.3 Infectious bronchitis
- 6.4 Infectious bursal diseases
- 6.5 Salmonella
- 6.6 Marek's disease
- 6.7 Egg drop syndrome
- 6.8 Adenovirus
- 6.9 Coccidiosis
- 6.10 Avian influenza
- 6.11 Infectious laryngotracheitis
- 6.12 Avian encephalomyelitis
- 6.13 Other disease types
- Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
- 7.1 Key trends
- 7.2 Breeder
- 7.3 Layer
- 7.4 Broiler
- Chapter 8 Market Estimates and Forecast, By Dosage Form, 2021 – 2032 ($ Mn)
- 8.1 Key trends
- 8.2 Liquid vaccine
- 8.3 Freeze dried vaccine
- Chapter 9 Market Estimates and Forecast, By End-user, 2021 – 2032 ($ Mn)
- 9.1 Key trends
- 9.2 Veterinary hospitals and clinics
- 9.3 Poultry farms
- Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
- 10.1 Key trends
- 10.2 North America
- 10.2.1 U.S.
- 10.2.2 Canada
- 10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 France
- 10.3.4 Spain
- 10.3.5 Italy
- 10.3.6 Netherlands
- 10.3.7 Rest of Europe
- 10.4 Asia Pacific
- 10.4.1 China
- 10.4.2 Japan
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 South Korea
- 10.4.6 Rest of Asia Pacific
- 10.5 Latin America
- 10.5.1 Brazil
- 10.5.2 Mexico
- 10.5.3 Rest of Latin America
- 10.6 Middle East and Africa
- 10.6.1 South Africa
- 10.6.2 Saudi Arabia
- 10.6.3 UAE
- 10.6.4 Rest of Middle East and Africa
- Chapter 11 Company Profiles
- 11.1 Biovac
- 11.2 Boehringer Ingelheim International GmbH
- 11.3 Ceva Sante Animale
- 11.4 Dechra Pharmaceuticals PLC
- 11.5 Elanco Animal Health Incorporated
- 11.6 Hester Biosciences Limited
- 11.7 HIPRA
- 11.8 Merck and Co., Inc.
- 11.9 Phibro Animal Health Corporation
- 11.10 Vaxxinova International BV
- 11.11 Venky's Limited
- 11.12 Zoetis, Inc.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.